The final scFv in the panel, AD-TDP3, was isolated against a human ALS brain-derived TDP-43 variant [26,27], but it also has strong reactivity with brain tissue and plasma samples from AD cases [33,34]. Here, TARDBP is linked to amyotrophic lateral sclerosis.